Immune Function Agents, Vitamins, Amino Acids and Coenzymes
Feed Grade, Medicine Grade
Packaging & Delivery
Setipiprant (INN) (developmental code names ACT-129,968, KYTH-105) is a drug originally developed by Actelionwhich acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2). It was initially researched as a treatment for allergies and inflammatory disorders, particularly asthma, but despite being well tolerated in clinical trials and showing reasonable efficacy against allergen-induced airway responses in asthmatic patients, it failed to show sufficient advantages over existing drugs and was discontinued from further development in this application.
1)Delivery time:within 3 days after got the order
Package Details:aluminum foil bag/dram/on request
More information,Please feel free to contact with us.